ACE and schizophrenia: In the US results, the ACE inhibitor group showed a higher risk of schizophrenia occurrence than the ARB group, including the total population and the subgroup (total population: calibrated HR 1.21 [95% CI, 1.13–1.29]; subgroup: calibrated HR 1.18 [95% CI, 1.09–1.27]).